-
1
-
-
0035499267
-
Stem cells, cancer, and cancer stem cells
-
PMID:11689955
-
Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414:105-11; PMID:11689955; http://dx.doi.org/10. 1038/35102167.
-
(2001)
Nature
, vol.414
, pp. 105-11
-
-
Reya, T.1
Morrison, S.J.2
Clarke, M.F.3
Weissman, I.L.4
-
2
-
-
36148991764
-
Cancer stem cells in solid tumors
-
PMID:18023337
-
Ailles LE, Weissman IL. Cancer stem cells in solid tumors. Curr Opin Biotechnol 2007; 18:460-6; PMID:18023337; http://dx.doi.org/10.1016/j.copbio. 2007.10.007.
-
(2007)
Curr Opin Biotechnol
, vol.18
, pp. 460-6
-
-
Ailles, L.E.1
Weissman, I.L.2
-
3
-
-
0028091194
-
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
-
PMID:7509044
-
Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994; 367:645-8; PMID:7509044; http://dx.doi.org/10.1038/ 367645a0.
-
(1994)
Nature
, vol.367
, pp. 645-8
-
-
Lapidot, T.1
Sirard, C.2
Vormoor, J.3
Murdoch, B.4
Hoang, T.5
Caceres-Cortes, J.6
-
4
-
-
0030789242
-
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
-
PMID:9212098
-
Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3:730-7; PMID:9212098; http://dx.doi.org/10.1038/nm0797-730.
-
(1997)
Nat Med
, vol.3
, pp. 730-7
-
-
Bonnet, D.1
Dick, J.E.2
-
5
-
-
0037388204
-
Prospective identification of tumorigenic breast cancer cells
-
PMID:12629218
-
Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003; 100:3983-8; PMID:12629218; http://dx.doi.org/10.1073/pnas. 0530291100.
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 3983-8
-
-
Al-Hajj, M.1
Wicha, M.S.2
Benito-Hernandez, A.3
Morrison, S.J.4
Clarke, M.F.5
-
6
-
-
21344454219
-
Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties
-
PMID:15994920
-
Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005; 65:5506-11; PMID:15994920; http://dx.doi.org/10.1158/0008-5472.CAN-05-0626.
-
(2005)
Cancer Res
, vol.65
, pp. 5506-11
-
-
Ponti, D.1
Costa, A.2
Zaffaroni, N.3
Pratesi, G.4
Petrangolini, G.5
Coradini, D.6
-
7
-
-
39449088496
-
Identification and expansion of the tumorigenic lung cancer stem cell population
-
PMID:18049477
-
Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 2008; 15:504-14; PMID:18049477; http://dx.doi.org/10.1038/sj.cdd.4402283.
-
(2008)
Cell Death Differ
, vol.15
, pp. 504-14
-
-
Eramo, A.1
Lotti, F.2
Sette, G.3
Pilozzi, E.4
Biffoni, M.5
Di Virgilio, A.6
-
8
-
-
0344735881
-
Cancerous stem cells can arise from pediatric brain tumors
-
PMID:14645703
-
Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A 2003; 100:15178-83; PMID:14645703; http://dx.doi.org/10.1073/pnas.2036535100.
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 15178-83
-
-
Hemmati, H.D.1
Nakano, I.2
Lazareff, J.A.3
Masterman-Smith, M.4
Geschwind, D.H.5
Bronner-Fraser, M.6
-
9
-
-
0141842674
-
Identification of a cancer stem cell in human brain tumors
-
PMID:14522905
-
Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63:5821-8; PMID:14522905.
-
(2003)
Cancer Res
, vol.63
, pp. 5821-8
-
-
Singh, S.K.1
Clarke, I.D.2
Terasaki, M.3
Bonn, V.E.4
Hawkins, C.5
Squire, J.6
-
10
-
-
4944250781
-
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma
-
PMID:15466194
-
Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004; 64:7011-21; PMID:15466194; http://dx.doi.org/10.1158/0008-5472.CAN-04-1364.
-
(2004)
Cancer Res
, vol.64
, pp. 7011-21
-
-
Galli, R.1
Binda, E.2
Orfanelli, U.3
Cipelletti, B.4
Gritti, A.5
De Vitis, S.6
-
11
-
-
33846100356
-
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
-
PMID:17122772
-
O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445:106-10; PMID:17122772; http://dx.doi.org/10.1038/nature05372.
-
(2007)
Nature
, vol.445
, pp. 106-10
-
-
O'Brien, C.A.1
Pollett, A.2
Gallinger, S.3
Dick, J.E.4
-
12
-
-
33846095137
-
Identification and expansion of human colon-cancer-initiating cells
-
PMID:17122771
-
Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445:111-5; PMID:17122771; http://dx.doi.org/10.1038/nature05384.
-
(2007)
Nature
, vol.445
, pp. 111-5
-
-
Ricci-Vitiani, L.1
Lombardi, D.G.2
Pilozzi, E.3
Biffoni, M.4
Todaro, M.5
Peschle, C.6
-
13
-
-
34848866647
-
Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4
-
PMID:18371377
-
Todaro M, Alea MP, Di Stefano AB, Cammareri P, Vermeulen L, Iovino F, et al. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 2007; 1:389-402; PMID:18371377; http://dx.doi.org/10.1016/j. stem.2007.08.001.
-
(2007)
Cell Stem Cell
, vol.1
, pp. 389-402
-
-
Todaro, M.1
Alea, M.P.2
Di Stefano, A.B.3
Cammareri, P.4
Vermeulen, L.5
Iovino, F.6
-
14
-
-
51649111430
-
Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity
-
PMID:18765800
-
Vermeulen L, Todaro M, de Sousa Mello F, Sprick MR, Kemper K, Perez Alea M, et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci U S A 2008; 105:13427-32; PMID:18765800; http://dx.doi.org/10.1073/pnas.0805706105.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 13427-32
-
-
Vermeulen, L.1
Todaro, M.2
De Sousa Mello, F.3
Sprick, M.R.4
Kemper, K.5
Perez Alea, M.6
-
15
-
-
28244472369
-
Prospective identification of tumorigenic prostate cancer stem cells
-
PMID:16322242
-
Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005; 65:10946-51; PMID:16322242; http://dx.doi.org/10.1158/0008-5472.CAN-05-2018.
-
(2005)
Cancer Res
, vol.65
, pp. 10946-51
-
-
Collins, A.T.1
Berry, P.A.2
Hyde, C.3
Stower, M.J.4
Maitland, N.J.5
-
16
-
-
33847052127
-
Identification of pancreatic cancer stem cells
-
PMID:17283135
-
Li CW, Heidt DG, Dalerba P, Burant CF, Zhang LJ, Adsay V, et al. Identification of pancreatic cancer stem cells. Cancer Res 2007; 67:1030-7; PMID:17283135; http://dx.doi.org/10.1158/0008-5472.CAN-06-2030.
-
(2007)
Cancer Res
, vol.67
, pp. 1030-7
-
-
Li, C.W.1
Heidt, D.G.2
Dalerba, P.3
Burant, C.F.4
Zhang, L.J.5
Adsay, V.6
-
17
-
-
73349125059
-
CD133 expression defines a tumor initiating cell population in primary human ovarian cancer
-
PMID:19816957
-
Curley MD, Therrien VA, Cummings CL, Sergent PA, Koulouris CR, Friel AM, et al. CD133 expression defines a tumor initiating cell population in primary human ovarian cancer. Stem Cells 2009; 27:2875-83; PMID:19816957.
-
(2009)
Stem Cells
, vol.27
, pp. 2875-83
-
-
Curley, M.D.1
Therrien, V.A.2
Cummings, C.L.3
Sergent, P.A.4
Koulouris, C.R.5
Friel, A.M.6
-
18
-
-
38549139140
-
Significance of CD90+ cancer stem cells in human liver cancer
-
PMID:18242515
-
Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, et al. Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 2008; 13:153-66; PMID:18242515; http://dx.doi.org/10.1016/j.ccr.2008.01.013.
-
(2008)
Cancer Cell
, vol.13
, pp. 153-66
-
-
Yang, Z.F.1
Ho, D.W.2
Ng, M.N.3
Lau, C.K.4
Yu, W.C.5
Ngai, P.6
-
19
-
-
33847639310
-
Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential
-
PMID:17320377
-
Monzani E, Facchetti F, Galmozzi E, Corsini E, Benetti A, Cavazzin C, et al. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer 2007; 43:935-46; PMID:17320377; http://dx.doi.org/10. 1016/j. ejca.2007.01.017.
-
(2007)
Eur J Cancer
, vol.43
, pp. 935-46
-
-
Monzani, E.1
Facchetti, F.2
Galmozzi, E.3
Corsini, E.4
Benetti, A.5
Cavazzin, C.6
-
20
-
-
16844368698
-
Tumour stem cells and drug resistance
-
PMID:15803154
-
Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer 2005; 5:275-84; PMID:15803154; http://dx.doi.org/10.1038/nrc1590.
-
(2005)
Nat Rev Cancer
, vol.5
, pp. 275-84
-
-
Dean, M.1
Fojo, T.2
Bates, S.3
-
21
-
-
64749116495
-
Are cancer stem cells real? After four decades, debate still simmers
-
PMID:19351923
-
Rowan K. Are cancer stem cells real? After four decades, debate still simmers. J Natl Cancer Inst 2009; 101:546-7; PMID:19351923; http://dx.doi.org/ 10.1093/jnci/djp083.
-
(2009)
J Natl Cancer Inst
, vol.101
, pp. 546-7
-
-
Rowan, K.1
-
22
-
-
45749114065
-
Cancer stem cells: Models, mechanisms and implications for improved treatment
-
PMID:18418062
-
Zhou J, Zhang Y. Cancer stem cells: Models, mechanisms and implications for improved treatment. Cell Cycle 2008; 7:1360-70; PMID:18418062; http://dx.doi.org/10.4161/cc.7.10.5953.
-
(2008)
Cell Cycle
, vol.7
, pp. 1360-70
-
-
Zhou, J.1
Zhang, Y.2
-
23
-
-
20444461067
-
Metformin and reduced risk of cancer in diabetic patients
-
PMID:15849206
-
Evans JM, Donnelly LA, Emslie-Smith AM, Alessi DR, Morris AD. Metformin and reduced risk of cancer in diabetic patients. BMJ 2005; 330:1304-5; PMID:15849206; http://dx.doi.org/10.1136/bmj.38415.708634.F7.
-
(2005)
BMJ
, vol.330
, pp. 1304-5
-
-
Evans, J.M.1
Donnelly, L.A.2
Emslie-Smith, A.M.3
Alessi, D.R.4
Morris, A.D.5
-
24
-
-
77955770568
-
Metformin and rapamycin have distinct effects on the akt pathway and proliferation in breast cancer cells
-
PMID:20135346
-
Zakikhani M, Blouin MJ, Piura E, Pollak MN. Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells. Breast Cancer Res Treat 2010; 123:271-9; PMID:20135346; http://dx.doi.org/10. 1007/s10549-010-0763-9.
-
(2010)
Breast Cancer Res Treat
, vol.123
, pp. 271-9
-
-
Zakikhani, M.1
Blouin, M.J.2
Piura, E.3
Pollak, M.N.4
-
25
-
-
58149156184
-
Therapeutic metforminampk activation promotes the angiogenic phenotype in the eralpha negative mdamb-435 breast cancer model
-
PMID:18256928
-
Phoenix KN, Vumbaca F, Claffey KP. Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDAMB-435 breast cancer model. Breast Cancer Res Treat 2009; 113:101-11; PMID:18256928; http://dx.doi.org/10.1007/s10549-008-9916-5.
-
(2009)
Breast Cancer Res Treat
, vol.113
, pp. 101-11
-
-
Phoenix, K.N.1
Vumbaca, F.2
Claffey, K.P.3
-
26
-
-
58149354390
-
Cell cycle arrest in metformin treated breast cancer cells involves activation of AMPK downregulation of cyclin D1 and requires p27Kip1 or p21cip1
-
PMID:19046439
-
Zhuang Y, Miskimins WK. Cell cycle arrest in Metformin treated breast cancer cells involves activation of AMPK, downregulation of cyclin D1, and requires p27Kip1 or p21Cip1. J Mol Signal 2008; 3:18; PMID:19046439; http://dx.doi.org/10.1186/1750-2187-3-18.
-
(2008)
J Mol Signal
, vol.3
, pp. 18
-
-
Zhuang, Y.1
Miskimins, W.K.2
-
27
-
-
78751692291
-
Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner
-
PMID:19874425
-
Rattan R, Giri S, Hartmann LC, Shridhar V. Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner. J Cell Mol Med 2011; 15:166-78; PMID:19874425; http://dx.doi.org/10.1111/j.1582-4934.2009.00954.x.
-
(2011)
J Cell Mol Med
, vol.15
, pp. 166-78
-
-
Rattan, R.1
Giri, S.2
Hartmann, L.C.3
Shridhar, V.4
-
28
-
-
70749106139
-
Metformin is a potent inhibitor of endometrial cancer cell proliferation-implications for a novel treatment strategy
-
PMID:19822355
-
Cantrell LA, Zhou C, Mendivil A, Malloy KM, Gehrig PA, Bae-Jump VL. Metformin is a potent inhibitor of endometrial cancer cell proliferation- implications for a novel treatment strategy. Gynecol Oncol 2010; 116:92-8; PMID:19822355; http://dx.doi.org/10.1016/j. ygyno.2009.09.024.
-
(2010)
Gynecol Oncol
, vol.116
, pp. 92-8
-
-
Cantrell, L.A.1
Zhou, C.2
Mendivil, A.3
Malloy, K.M.4
Gehrig, P.A.5
Bae-Jump, V.L.6
-
29
-
-
77955458963
-
The combination of metformin and 2 deoxyglucose inhibits autophagy and induces AMPK-dependent apoptosis in prostate cancer cells
-
PMID:20559023
-
Ben Sahra I, Tanti JF, Bost F. The combination of metformin and 2 deoxyglucose inhibits autophagy and induces AMPK-dependent apoptosis in prostate cancer cells. Autophagy 2010; 6:670-1; PMID:20559023; http://dx.doi.org/10. 4161/auto.6.5.12434.
-
(2010)
Autophagy
, vol.6
, pp. 670-1
-
-
Ben Sahra, I.1
Tanti, J.F.2
Bost, F.3
-
30
-
-
44849099894
-
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
-
PMID:18212742
-
Ben Sahra I, Laurent K, Loubat A, Giorgetti-Peraldi S, Colosetti P, Auberger P, et al. The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level. Oncogene 2008; 27:3576-86; PMID:18212742; http://dx.doi.org/10.1038/sj.onc.1211024.
-
(2008)
Oncogene
, vol.27
, pp. 3576-86
-
-
Ben Sahra, I.1
Laurent, K.2
Loubat, A.3
Giorgetti-Peraldi, S.4
Colosetti, P.5
Auberger, P.6
-
31
-
-
77951708711
-
Crosstalk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: A novel target for the antidiabetic drug metformin in pancreatic cancer
-
PMID:20388847
-
Rozengurt E, Sinnett-Smith J, Kisfalvi K. Crosstalk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: A novel target for the antidiabetic drug metformin in pancreatic cancer. Clin Cancer Res 2010; 16:2505-11; PMID:20388847; http://dx.doi.org/10.1158/1078-0432.CCR-09-2229.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 2505-11
-
-
Rozengurt, E.1
Sinnett-Smith, J.2
Kisfalvi, K.3
-
32
-
-
70350236538
-
Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission
-
PMID:19752085
-
Hirsch HA, Iliopoulos D, Tsichlis PN, Struhl K. Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res 2009; 69:7507-11; PMID:19752085; http://dx.doi.org/10.1158/0008-5472.CAN-09-2994.
-
(2009)
Cancer Res
, vol.69
, pp. 7507-11
-
-
Hirsch, H.A.1
Iliopoulos, D.2
Tsichlis, P.N.3
Struhl, K.4
-
33
-
-
68749099671
-
Identification of selective inhibitors of cancer stem cells by high-throughput screening
-
PMID:19682730
-
Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009; 138:645-59; PMID:19682730; http://dx.doi.org/10.1016/j. cell.2009.06.034.
-
(2009)
Cell
, vol.138
, pp. 645-59
-
-
Gupta, P.B.1
Onder, T.T.2
Jiang, G.3
Tao, K.4
Kuperwasser, C.5
Weinberg, R.A.6
-
34
-
-
77950867732
-
Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells
-
PMID:20350531
-
Fuchs D, Daniel V, Sadeghi M, Opelz G, Naujokat C. Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells. Biochem Biophys Res Commun 2010; 394:1098-104; PMID:20350531; http://dx.doi.org/10.1016/j.bbrc.2010.03.138.
-
(2010)
Biochem Biophys Res Commun
, vol.394
, pp. 1098-104
-
-
Fuchs, D.1
Daniel, V.2
Sadeghi, M.3
Opelz, G.4
Naujokat, C.5
-
35
-
-
77956954455
-
Selective targeting of neuroblastoma tumour-initiating cells by compounds identified in stem cell-based small molecule screens
-
PMID:20721990
-
Smith KM, Datti A, Fujitani M, Grinshtein N, Zhang L, Morozova O, et al. Selective targeting of neuroblastoma tumour-initiating cells by compounds identified in stem cell-based small molecule screens. EMBO Mol Med 2010; 2:371-84; PMID:20721990; http://dx.doi.org/10.1002/emmm.201000093.
-
(2010)
EMBO Mol Med
, vol.2
, pp. 371-84
-
-
Smith, K.M.1
Datti, A.2
Fujitani, M.3
Grinshtein, N.4
Zhang, L.5
Morozova, O.6
-
37
-
-
77953155085
-
Oncostatin M Renders Epithelial Cell Adhesion Molecule-positive Liver Cancer Stem Cells Sensitive To 5-Fluorouracil by inducing hepatocytic differentiation
-
PMID:20484035
-
Yamashita T, Honda M, Nio K, Nakamoto Y, Yamashita T, Takamura H, et al. Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-Fluorouracil by inducing hepatocytic differentiation. Cancer Res 2010; 70:4687-97; PMID:20484035; http://dx.doi.org/10.1158/0008-5472. CAN-09-4210.
-
(2010)
Cancer Res
, vol.70
, pp. 4687-97
-
-
Yamashita, T.1
Honda, M.2
Nio, K.3
Nakamoto, Y.4
Yamashita, T.5
Takamura, H.6
-
38
-
-
77951730125
-
Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells
-
PMID:20388854
-
Li Y, Zhang T, Korkaya H, Liu S, Lee HF, Newman B, et al. Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clin Cancer Res 2010; 16:2580-90; PMID:20388854; http://dx.doi.org/10. 1158/1078-0432.CCR-09-2937.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 2580-90
-
-
Li, Y.1
Zhang, T.2
Korkaya, H.3
Liu, S.4
Lee, H.F.5
Newman, B.6
-
39
-
-
77955641868
-
The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition
-
PMID:20718984
-
Tang SN, Singh C, Nall D, Meeker D, Shankar S, Srivastava RK. The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition. J Mol Signal 2010; 18:5-14; PMID:20718984.
-
(2010)
J Mol Signal
, vol.18
, pp. 5-14
-
-
Tang, S.N.1
Singh, C.2
Nall, D.3
Meeker, D.4
Shankar, S.5
Srivastava, R.K.6
-
40
-
-
77956543290
-
Dietary polyphenol quercetin targets pancreatic cancer stem cells
-
PMID:20664924
-
Zhou W, Kallifatidis G, Baumann B, Rausch V, Mattern J, Gladkich J, et al. Dietary polyphenol quercetin targets pancreatic cancer stem cells. Int J Oncol 2010; 37:551-61; PMID:20664924.
-
(2010)
Int J Oncol
, vol.37
, pp. 551-61
-
-
Zhou, W.1
Kallifatidis, G.2
Baumann, B.3
Rausch, V.4
Mattern, J.5
Gladkich, J.6
-
41
-
-
79952825166
-
Chemoresistance of lung cancer stemlike cells depends on activation of Hsp27
-
PMID:21425153
-
Hsu HS, Lin JH, Huang WC, Hsu TW, Su K, Chiou SH, et al. Chemoresistance of lung cancer stemlike cells depends on activation of Hsp27. Cancer 2011; 117:1516-28; PMID:21425153; http://dx.doi.org/10.1002/cncr.25599.
-
(2011)
Cancer
, vol.117
, pp. 1516-28
-
-
Hsu, H.S.1
Lin, J.H.2
Huang, W.C.3
Hsu, T.W.4
Su, K.5
Chiou, S.H.6
-
42
-
-
77952420903
-
Curcumin inhibits the side population (SP) phenotype of the rat c6 glioma cell line: Towards targeting of cancer stem cells with phytochemicals
-
PMID:20089354
-
Fong D, Yeh A, Naftalovich R, Choi TH, Chan MM. Curcumin inhibits the side population (SP) phenotype of the rat C6 glioma cell line: Towards targeting of cancer stem cells with phytochemicals. Cancer Lett 2010; 293:65-72; PMID:20089354; http://dx.doi.org/10.1016/j.canlet.2009.12.018.
-
(2010)
Cancer Lett
, vol.293
, pp. 65-72
-
-
Fong, D.1
Yeh, A.2
Naftalovich, R.3
Choi, T.H.4
Chan, M.M.5
-
43
-
-
57149096060
-
Berberine diminishes the side population and ABCG2 transporter expression in MCF-7 breast cancer cells
-
PMID:18951337
-
Kim JB, Ko E, Han W, Shin I, Park SY, Noh DY. Berberine diminishes the side population and ABCG2 transporter expression in MCF-7 breast cancer cells. Planta Med 2008; 74:1693-700; PMID:18951337; http://dx.doi.org/10.1055/s-0028- 1088313.
-
(2008)
Planta Med
, vol.74
, pp. 1693-700
-
-
Kim, J.B.1
Ko, E.2
Han, W.3
Shin, I.4
Park, S.Y.5
Noh, D.Y.6
-
44
-
-
79952463186
-
Gamma-tocotrienol as an effective agent in targeting prostate cancer stem cell-like population
-
PMID:20617516
-
Luk SU, Yap WN, Chiu YT, Lee DT, Ma S, Lee TK, et al. Gamma-tocotrienol as an effective agent in targeting prostate cancer stem cell-like population. Int J Cancer 2011; 128:2182-91; PMID:20617516; http://dx.doi.org/10.1002/ijc. 25546.
-
(2011)
Int J Cancer
, vol.128
, pp. 2182-91
-
-
Luk, S.U.1
Yap, W.N.2
Chiu, Y.T.3
Lee, D.T.4
Ma, S.5
Lee, T.K.6
-
45
-
-
44649133215
-
A potential target associated with both cancer and cancer stem cells: A combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes
-
PMID:18466993
-
Liu Y, Lu WL, Guo J, Du J, Li T, Wu JW, et al. A potential target associated with both cancer and cancer stem cells: A combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes. J Control Release 2008; 129:18-25; PMID:18466993; http://dx.doi.org/10.1016/j.jconrel.2008.03.022.
-
(2008)
J Control Release
, vol.129
, pp. 18-25
-
-
Liu, Y.1
Lu, W.L.2
Guo, J.3
Du, J.4
Li, T.5
Wu, J.W.6
-
46
-
-
3042569646
-
Phytoestrogensflavonoids Reverse Breast Cancer Resistance ProteinABCG2-mediated multidrug resistance
-
PMID:15205350
-
Imai Y, Tsukahara S, Asada S, Sugimoto Y. Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance. Cancer Res 2004; 64:4346-52; PMID:15205350; http://dx.doi.org/10.1158/0008-5472. CAN-04-0078.
-
(2004)
Cancer Res
, vol.64
, pp. 4346-52
-
-
Imai, Y.1
Tsukahara, S.2
Asada, S.3
Sugimoto, Y.4
-
47
-
-
4344564103
-
Oncolytic viruses for the treatment of cancer: Current strategies and clinical trials
-
PMID:15450242
-
Ries SJ, Brandts CH. Oncolytic viruses for the treatment of cancer: Current strategies and clinical trials. Drug Discov Today 2004; 9:759-68; PMID:15450242; http://dx.doi.org/10.1016/S1359-6446(04)03221-0.
-
(2004)
Drug Discov Today
, vol.9
, pp. 759-68
-
-
Ries, S.J.1
Brandts, C.H.2
-
48
-
-
48649086074
-
Tissue-specific promoters active in CD44+CD24-/low breast cancer cells
-
PMID:18632604
-
Bauerschmitz GJ, Ranki T, Kangasniemi L, Ribacka C, Eriksson M, Porten M, et al. Tissue-specific promoters active in CD44+CD24-/low breast cancer cells. Cancer Res 2008; 68:5533-9; PMID:18632604; http://dx.doi.org/10.1158/0008-5472. CAN-07-5288.
-
(2008)
Cancer Res
, vol.68
, pp. 5533-9
-
-
Bauerschmitz, G.J.1
Ranki, T.2
Kangasniemi, L.3
Ribacka, C.4
Eriksson, M.5
Porten, M.6
-
49
-
-
52049099166
-
Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus
-
PMID:18451249
-
Zhang X, Komaki R, Wang L, Fang B, Chang JY. Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus. Clin Cancer Res 2008; 14:2813-23; PMID:18451249; http://dx.doi.org/10.1158/1078-0432.CCR-07-1528.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 2813-23
-
-
Zhang, X.1
Komaki, R.2
Wang, L.3
Fang, B.4
Chang, J.Y.5
-
50
-
-
3042767202
-
MicroRNAs: Small RNAs with a big role in gene regulation
-
PMID:15211354
-
He L, Hannon GJ. MicroRNAs: Small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5:522-31; PMID:15211354; http://dx.doi.org/10. 1038/nrg1379.
-
(2004)
Nat Rev Genet
, vol.5
, pp. 522-31
-
-
He, L.1
Hannon, G.J.2
-
51
-
-
61349141809
-
Clinicopathological significance of microRNA-31, 143 and-145 expression in colorectal cancer
-
PMID:19242066
-
Wang CJ, Zhou ZG, Wang L, Yang L, Zhou B, Gu J, et al. Clinicopathological significance of microRNA-31,-143 and-145 expression in colorectal cancer. Dis Markers 2009; 26:27-34; PMID:19242066.
-
(2009)
Dis Markers
, vol.26
, pp. 27-34
-
-
Wang, C.J.1
Zhou, Z.G.2
Wang, L.3
Yang, L.4
Zhou, B.5
Gu, J.6
-
52
-
-
63149123608
-
Uncovering growth-suppressive MicroRNAs in lung cancer
-
PMID:19228723
-
Liu X, Sempere LF, Galimberti F, Freemantle SJ, Black C, Dragnev KH, et al. Uncovering growth-suppressive MicroRNAs in lung cancer. Clin Cancer Res 2009; 15:1177-83; PMID:19228723; http://dx.doi.org/10.1158/1078-0432.CCR-08- 1355.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 1177-83
-
-
Liu, X.1
Sempere, L.F.2
Galimberti, F.3
Freemantle, S.J.4
Black, C.5
Dragnev, K.H.6
-
53
-
-
22244467087
-
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells
-
PMID:16024602
-
Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005; 65:6029-33; PMID:16024602; http://dx.doi.org/10.1158/0008-5472.CAN-05-0137.
-
(2005)
Cancer Res
, vol.65
, pp. 6029-33
-
-
Chan, J.A.1
Krichevsky, A.M.2
Kosik, K.S.3
-
54
-
-
55549120234
-
MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis
-
PMID:18812439
-
Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 2008; 14:2348-60; PMID:18812439; http://dx.doi.org/10.1261/rna.1034808.
-
(2008)
RNA
, vol.14
, pp. 2348-60
-
-
Yan, L.X.1
Huang, X.F.2
Shao, Q.3
Huang, M.Y.4
Deng, L.5
Wu, Q.L.6
-
55
-
-
23844555119
-
MicroRNA gene expression deregulation in human breast cancer
-
PMID:16103053
-
Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65:7065-70; PMID:16103053; http://dx.doi.org/10.1158/0008-5472.CAN-05-1783.
-
(2005)
Cancer Res
, vol.65
, pp. 7065-70
-
-
Iorio, M.V.1
Ferracin, M.2
Liu, C.G.3
Veronese, A.4
Spizzo, R.5
Sabbioni, S.6
-
56
-
-
34547458550
-
P53-mediated activation of miRNA34 candidate tumor-suppressor genes
-
PMID:17656095
-
Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE, et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 2007; 17:1298-307; PMID:17656095; http://dx.doi.org/10.1016/j.cub.2007.06.068.
-
(2007)
Curr Biol
, vol.17
, pp. 1298-307
-
-
Bommer, G.T.1
Gerin, I.2
Feng, Y.3
Kaczorowski, A.J.4
Kuick, R.5
Love, R.E.6
-
57
-
-
34250851115
-
A microRNA component of the p53 tumour suppressor network
-
PMID:17554337
-
He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, et al. A microRNA component of the p53 tumour suppressor network. Nature 2007; 447:1130-4; PMID:17554337; http://dx.doi.org/10.1038/nature05939.
-
(2007)
Nature
, vol.447
, pp. 1130-4
-
-
He, L.1
He, X.2
Lim, L.P.3
De Stanchina, E.4
Xuan, Z.5
Liang, Y.6
-
58
-
-
53949090314
-
Restoration of tumor suppressor MiR-34 inhibits human P53-mutant gastric cancer tumorspheres
-
PMID:18803879
-
Ji Q, Hao X, Meng Y, Zhang M, Desano J, Fan D, et al. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer 2008; 8:266; PMID:18803879; http://dx.doi.org/10.1186/1471-2407-8- 266.
-
(2008)
BMC Cancer
, vol.8
, pp. 266
-
-
Ji, Q.1
Hao, X.2
Meng, Y.3
Zhang, M.4
Desano, J.5
Fan, D.6
-
59
-
-
69949087531
-
MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells
-
PMID:19714243
-
Ji Q, Hao X, Zhang M, Tang W, Yang M, Li L, et al. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One 2009; 4:e6816; PMID:19714243; http://dx.doi.org/10.1371/journal. pone.0006816.
-
(2009)
PLoS One
, vol.4
-
-
Ji, Q.1
Hao, X.2
Zhang, M.3
Tang, W.4
Yang, M.5
Li, L.6
-
60
-
-
83355166283
-
Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethaneshort branch PEI
-
PMID:22098779
-
Yang YP, Chien Y, Chiou GY, Cherng JY, Wang ML, Lo WL, et al. Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethaneshort branch PEI. Biomaterials 2012; 33:1462-76; PMID:22098779; http://dx.doi.org/10.1016/j. biomaterials. 2011.10.071.
-
(2012)
Biomaterials
, vol.33
, pp. 1462-76
-
-
Yang, Y.P.1
Chien, Y.2
Chiou, G.Y.3
Cherng, J.Y.4
Wang, M.L.5
Lo, W.L.6
-
61
-
-
54049115162
-
An orally bioavailable smallmolecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer
-
PMID:18790753
-
Feldmann G, Fendrich V, McGovern K, Bedja D, Bisht S, Alvarez H, et al. An orally bioavailable smallmolecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer. Mol Cancer Ther 2008; 7:2725-35; PMID:18790753; http://dx.doi.org/10.1158/1535-7163.MCT-08-0573.
-
(2008)
Mol Cancer Ther
, vol.7
, pp. 2725-35
-
-
Feldmann, G.1
Fendrich, V.2
McGovern, K.3
Bedja, D.4
Bisht, S.5
Alvarez, H.6
-
62
-
-
60849118097
-
A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development
-
PMID:19174553
-
Jimeno A, Feldmann G, Suárez-Gauthier A, Rasheed Z, Solomon A, Zou GM, et al. A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development. Mol Cancer Ther 2009; 8:310-4; PMID:19174553; http://dx.doi.org/10.1158/1535-7163.MCT-08-0924.
-
(2009)
Mol Cancer Ther
, vol.8
, pp. 310-4
-
-
Jimeno, A.1
Feldmann, G.2
Suárez-Gauthier, A.3
Rasheed, Z.4
Solomon, A.5
Zou, G.M.6
-
63
-
-
69249156565
-
Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer
-
PMID:19501590
-
Mueller MT, Hermann PC, Witthauer J, Rubio-Viqueira B, Leicht SF, Huber S, et al. Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer. Gastroenterology 2009; 137:1102-13; PMID:19501590; http://dx.doi.org/10.1053/j.gastro.2009.05.053.
-
(2009)
Gastroenterology
, vol.137
, pp. 1102-13
-
-
Mueller, M.T.1
Hermann, P.C.2
Witthauer, J.3
Rubio-Viqueira, B.4
Leicht, S.F.5
Huber, S.6
-
64
-
-
35348837163
-
Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma
-
PMID:17628016
-
Bar EE, Chaudhry A, Lin A, Fan X, Schreck K, Matsui W, et al. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells 2007; 25:2524-33; PMID:17628016; http://dx.doi.org/10.1634/stemcells.2007-0166.
-
(2007)
Stem Cells
, vol.25
, pp. 2524-33
-
-
Bar, E.E.1
Chaudhry, A.2
Lin, A.3
Fan, X.4
Schreck, K.5
Matsui, W.6
-
65
-
-
76549084826
-
Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor
-
PMID:20068161
-
Harrison H, Farnie G, Howell SJ, Rock RE, Stylianou S, Brennan KR, et al. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res 2010; 70:709-18; PMID:20068161; http://dx.doi.org/10.1158/ 0008-5472.CAN-09-1681.
-
(2010)
Cancer Res
, vol.70
, pp. 709-18
-
-
Harrison, H.1
Farnie, G.2
Howell, S.J.3
Rock, R.E.4
Stylianou, S.5
Brennan, K.R.6
-
66
-
-
67849124654
-
DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency
-
PMID:19664991
-
Hoey T, Yen WC, Axelrod F, Basi J, Donigian L, Dylla S, et al. DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency. Cell Stem Cell 2009; 5:168-77; PMID:19664991; http://dx.doi.org/10.1016/j.stem.2009. 05.019.
-
(2009)
Cell Stem Cell
, vol.5
, pp. 168-77
-
-
Hoey, T.1
Yen, W.C.2
Axelrod, F.3
Basi, J.4
Donigian, L.5
Dylla, S.6
-
67
-
-
84655176705
-
Oxymatrine diminishes the side population and inhibits the expression of β-catenin in MCF-7 breast cancer cells
-
PMID:21069479
-
Zhang Y, Piao B, Zhang Y, Hua B, Hou W, Xu W, et al. Oxymatrine diminishes the side population and inhibits the expression of β-catenin in MCF-7 breast cancer cells. Med Oncol 2011; 28(Suppl 1):S99-107; PMID:21069479; http://dx.doi.org/10.1007/s12032-010-9721-y.
-
(2011)
Med Oncol
, vol.28
, Issue.SUPPL. 1
-
-
Zhang, Y.1
Piao, B.2
Zhang, Y.3
Hua, B.4
Hou, W.5
Xu, W.6
-
68
-
-
79958098183
-
PDGF-B Can sustain self-renewal and tumorigenicity of experimental glioma-derived cancer-initiating cells by preventing oligodendrocyte differentiation
-
PMID:21677873
-
Jiang Y, Boije M, Westermark B, Uhrbom L. PDGF-B Can sustain self-renewal and tumorigenicity of experimental glioma-derived cancer-initiating cells by preventing oligodendrocyte differentiation. Neoplasia 2011; 13:492-503; PMID:21677873.
-
(2011)
Neoplasia
, vol.13
, pp. 492-503
-
-
Jiang, Y.1
Boije, M.2
Westermark, B.3
Uhrbom, L.4
-
69
-
-
84867334428
-
Long-term exposure to imatinib reduced cancer stem cell ability through induction of cell differentiation via activation of MAPK signaling in glioblastoma cells
-
PMID:22829019
-
Dong Y, Han Q, Zou Y, Deng Z, Lu X, Wang X, et al. Long-term exposure to imatinib reduced cancer stem cell ability through induction of cell differentiation via activation of MAPK signaling in glioblastoma cells. Mol Cell Biochem 2012; 370:89-102; PMID:22829019; http://dx.doi.org/10.1007/s11010-012- 1401-0.
-
(2012)
Mol Cell Biochem
, vol.370
, pp. 89-102
-
-
Dong, Y.1
Han, Q.2
Zou, Y.3
Deng, Z.4
Lu, X.5
Wang, X.6
-
71
-
-
0033210894
-
Selectivity of TRAIL-mediated apoptosis of cancer cells and synergy with drugs: The trail to non-toxic cancer therapeutics (review)
-
PMID:10493964
-
Bonavida B, Ng CP, Jazirehi A, Schiller G, Mizutani Y. Selectivity of TRAIL-mediated apoptosis of cancer cells and synergy with drugs: The trail to non-toxic cancer therapeutics (review). Int J Oncol 1999; 15:793-802; PMID:10493964.
-
(1999)
Int J Oncol
, vol.15
, pp. 793-802
-
-
Bonavida, B.1
Ng, C.P.2
Jazirehi, A.3
Schiller, G.4
Mizutani, Y.5
-
72
-
-
50949107305
-
CD133-positive cells are resistant to TRAIL due to up-regulation of FLIP
-
PMID:18590703
-
Zobalova R, McDermott L, Stantic M, Prokopova K, Dong LF, Neuzil J. CD133-positive cells are resistant to TRAIL due to up-regulation of FLIP. Biochem Biophys Res Commun 2008; 373:567-71; PMID:18590703; http://dx.doi.org/ 10.1016/j.bbrc.2008.06.073.
-
(2008)
Biochem Biophys Res Commun
, vol.373
, pp. 567-71
-
-
Zobalova, R.1
McDermott, L.2
Stantic, M.3
Prokopova, K.4
Dong, L.F.5
Neuzil, J.6
-
73
-
-
65649086790
-
Stem-cell-like glioma cells are resistant to TRAILApo2L and exhibit downregulation of caspase-8 by promoter methylation
-
PMID:19214542
-
Capper D, Gaiser T, Hartmann C, Habel A, Mueller W, Herold-Mende C, et al. Stem-cell-like glioma cells are resistant to TRAIL/Apo2L and exhibit downregulation of caspase-8 by promoter methylation. Acta Neuropathol 2009; 117:445-56; PMID:19214542; http://dx.doi.org/10.1007/s00401-009-0494-3.
-
(2009)
Acta Neuropathol
, vol.117
, pp. 445-56
-
-
Capper, D.1
Gaiser, T.2
Hartmann, C.3
Habel, A.4
Mueller, W.5
Herold-Mende, C.6
-
74
-
-
42549144516
-
Chemotherapy-resistant side-population of colon cancer cells has a higher sensitivity to TRAIL than the non-SP, a higher expression of c-Myc and TRAILreceptor DR4
-
PMID:17881904
-
Sussman RT, Ricci MS, Hart LS, Sun SY, El-Deiry WS. Chemotherapy- resistant side-population of colon cancer cells has a higher sensitivity to TRAIL than the non-SP, a higher expression of c-Myc and TRAILreceptor DR4. Cancer Biol Ther 2007; 6:1490-5; PMID:17881904; http://dx.doi.org/10.4161/cbt.6. 9.4905.
-
(2007)
Cancer Biol Ther
, vol.6
, pp. 1490-5
-
-
Sussman, R.T.1
Ricci, M.S.2
Hart, L.S.3
Sun, S.Y.4
El-Deiry, W.S.5
-
75
-
-
43049139914
-
Inflammation and tumor microenvironments: Defining the migratory itinerary of mesenchymal stem cells
-
PMID:18401438
-
Spaeth E, Klopp A, Dembinski J, Andreeff M, Marini F. Inflammation and tumor microenvironments: Defining the migratory itinerary of mesenchymal stem cells. Gene Ther 2008; 15:730-8; PMID:18401438; http://dx.doi.org/10.1038/gt. 2008.39.
-
(2008)
Gene Ther
, vol.15
, pp. 730-8
-
-
Spaeth, E.1
Klopp, A.2
Dembinski, J.3
Andreeff, M.4
Marini, F.5
-
76
-
-
79951602634
-
Therapeutic efficacy and safety of TRAILproducing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma
-
PMID:21062796
-
Choi SA, Hwang SK, Wang KC, Cho BK, Phi JH, Lee JY, et al. Therapeutic efficacy and safety of TRAILproducing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma. Neuro Oncol 2011; 13:61-9; PMID:21062796; http://dx.doi.org/10.1093/neuonc/noq147.
-
(2011)
Neuro Oncol
, vol.13
, pp. 61-9
-
-
Choi, S.A.1
Hwang, S.K.2
Wang, K.C.3
Cho, B.K.4
Phi, J.H.5
Lee, J.Y.6
-
77
-
-
56249091888
-
Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model
-
PMID:18373740
-
Mohr A, Lyons M, Deedigan L, Harte T, Shaw G, Howard L, et al. Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model. J Cell Mol Med 2008; 12(6B):2628-43; PMID:18373740; http://dx.doi.org/10.1111/j.1582-4934.2008.00317.x.
-
(2008)
J Cell Mol Med
, vol.12
, Issue.6 B
, pp. 2628-43
-
-
Mohr, A.1
Lyons, M.2
Deedigan, L.3
Harte, T.4
Shaw, G.5
Howard, L.6
-
78
-
-
78650187516
-
TRAILexpressing mesenchymal stem cells kill the putative cancer stem cell population
-
PMID:21063402
-
Loebinger MR, Sage EK, Davies D, Janes SM. TRAILexpressing mesenchymal stem cells kill the putative cancer stem cell population. Br J Cancer 2010; 103:1692-7; PMID:21063402; http://dx.doi.org/10.1038/sj.bjc.6605952.
-
(2010)
Br J Cancer
, vol.103
, pp. 1692-7
-
-
Loebinger, M.R.1
Sage, E.K.2
Davies, D.3
Janes, S.M.4
-
79
-
-
0035134688
-
Interferon in oncological practice: Review of interferon biology, clinical applications, and toxicities
-
PMID:11161227
-
Jonasch E, Haluska FG. Interferon in oncological practice: Review of interferon biology, clinical applications, and toxicities. Oncologist 2001; 6:34-55; PMID:11161227; http://dx.doi.org/10.1634/theoncologist. 6-1-34.
-
(2001)
Oncologist
, vol.6
, pp. 34-55
-
-
Jonasch, E.1
Haluska, F.G.2
-
80
-
-
17844411255
-
Role of inflammatory mediators in angiogenesis
-
PMID:15720228
-
Naldini A, Carraro F. Role of inflammatory mediators in angiogenesis. Curr Drug Targets Inflamm Allergy 2005; 4:3-8; PMID:15720228; http://dx.doi.org/10.2174/1568010053622830.
-
(2005)
Curr Drug Targets Inflamm Allergy
, vol.4
, pp. 3-8
-
-
Naldini, A.1
Carraro, F.2
-
81
-
-
48649101859
-
The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects
-
PMID:18632618
-
Moserle L, Indraccolo S, Ghisi M, Frasson C, Fortunato E, Canevari S, et al. The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects. Cancer Res 2008; 68:5658-68; PMID:18632618; http://dx.doi.org/10.1158/0008-5472.CAN-07-6341.
-
(2008)
Cancer Res
, vol.68
, pp. 5658-68
-
-
Moserle, L.1
Indraccolo, S.2
Ghisi, M.3
Frasson, C.4
Fortunato, E.5
Canevari, S.6
-
82
-
-
79955469335
-
Side population is increased in paclitaxel-resistant ovarian cancer cell lines regardless of resistance to cisplatin
-
PMID:21272926
-
Kobayashi Y, Seino K, Hosonuma S, Ohara T, Itamochi H, Isonishi S, et al. Side population is increased in paclitaxel-resistant ovarian cancer cell lines regardless of resistance to cisplatin. Gynecol Oncol 2011; 121:390-4; PMID:21272926; http://dx.doi.org/10.1016/j. ygyno.2010.12.366.
-
(2011)
Gynecol Oncol
, vol.121
, pp. 390-4
-
-
Kobayashi, Y.1
Seino, K.2
Hosonuma, S.3
Ohara, T.4
Itamochi, H.5
Isonishi, S.6
-
83
-
-
69049120195
-
Induction of oligodendrogenesis in glioblastoma-initiating cells by IFN-mediated activation of STAT3 signaling
-
PMID:19457609
-
Yuki K, Natsume A, Yokoyama H, Kondo Y, Ohno M, Kato T, et al. Induction of oligodendrogenesis in glioblastoma-initiating cells by IFN-mediated activation of STAT3 signaling. Cancer Lett 2009; 284:71-9; PMID:19457609; http://dx.doi.org/10.1016/j.canlet. 2009.04.020.
-
(2009)
Cancer Lett
, vol.284
, pp. 71-9
-
-
Yuki, K.1
Natsume, A.2
Yokoyama, H.3
Kondo, Y.4
Ohno, M.5
Kato, T.6
-
84
-
-
0029895383
-
Refining the telomere-telomerase hypothesis of aging and cancer
-
PMID:9631006
-
Holt SE, Shay JW, Wright WE. Refining the telomere-telomerase hypothesis of aging and cancer. Nat Biotechnol 1996; 14:836-9; PMID:9631006; http://dx.doi.org/10.1038/nbt0796-836.
-
(1996)
Nat Biotechnol
, vol.14
, pp. 836-9
-
-
Holt, S.E.1
Shay, J.W.2
Wright, W.E.3
-
85
-
-
77953673123
-
Imetelstat (GRN163L)-telomerase-based cancer therapy
-
PMID:20072842
-
Röth A, Harley CB, Baerlocher GM. Imetelstat (GRN163L)-telomerase- based cancer therapy. Recent Results Cancer Res 2010; 184:221-34; PMID:20072842; http://dx.doi.org/10.1007/978-3-642-01222-8-16.
-
(2010)
Recent Results Cancer Res
, vol.184
, pp. 221-34
-
-
Röth, A.1
Harley, C.B.2
Baerlocher, G.M.3
-
86
-
-
77958584577
-
Telomerase inhibition targets clonogenic multiple myeloma cells through telomere lengthdependent and independent mechanisms
-
PMID:20824134
-
Brennan SK, Wang Q, Tressler R, Harley C, Go N, Bassett E, et al. Telomerase inhibition targets clonogenic multiple myeloma cells through telomere lengthdependent and independent mechanisms. PLoS One 2010; 5; PMID:20824134; http://dx.doi.org/10.1371/journal.pone.0012487.
-
PLoS One
, vol.2010
, pp. 5
-
-
Brennan, S.K.1
Wang, Q.2
Tressler, R.3
Harley, C.4
Go, N.5
Bassett, E.6
-
87
-
-
78549257138
-
The telomerase inhibitor imetelstat depletes cancer stem cells in breast and pancreatic cancer cell lines
-
PMID:21062983
-
Joseph I, Tressler R, Bassett E, Harley C, Buseman CM, Pattamatta P, et al. The telomerase inhibitor imetelstat depletes cancer stem cells in breast and pancreatic cancer cell lines. Cancer Res 2010; 70:9494-504; PMID:21062983; http://dx.doi.org/10.1158/0008-5472.CAN-10-0233.
-
(2010)
Cancer Res
, vol.70
, pp. 9494-504
-
-
Joseph, I.1
Tressler, R.2
Bassett, E.3
Harley, C.4
Buseman, C.M.5
Pattamatta, P.6
-
88
-
-
74949143829
-
The telomerase antagonist, imetelstat, efficiently targets glioblastoma tumor-initiating cells leading to decreased proliferation and tumor growth
-
PMID:20048334
-
Marian CO, Cho SK, McEllin BM, Maher EA, Hatanpaa KJ, Madden CJ, et al. The telomerase antagonist, imetelstat, efficiently targets glioblastoma tumor-initiating cells leading to decreased proliferation and tumor growth. Clin Cancer Res 2010; 16:154-63; PMID:20048334; http://dx.doi.org/10.1158/1078-0432. CCR-09-2850.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 154-63
-
-
Marian, C.O.1
Cho, S.K.2
McEllin, B.M.3
Maher, E.A.4
Hatanpaa, K.J.5
Madden, C.J.6
-
90
-
-
78751558930
-
All-trans retinoic acid modulates cancer stem cells of glioblastoma multiforme in an MAPKdependent manner
-
PMID:21187470
-
Karsy M, Albert L, Tobias ME, Murali R, Jhanwar-Uniyal M. All-trans retinoic acid modulates cancer stem cells of glioblastoma multiforme in an MAPKdependent manner. Anticancer Res 2010; 30:4915-20; PMID:21187470.
-
(2010)
Anticancer Res
, vol.30
, pp. 4915-20
-
-
Karsy, M.1
Albert, L.2
Tobias, M.E.3
Murali, R.4
Jhanwar-Uniyal, M.5
-
91
-
-
84862118662
-
Nuclear receptors agonists exert opposing effects on the inflammation dependent survival of breast cancer stem cells
-
PMID:22261616
-
Papi A, Guarnieri T, Storci G, Santini D, Ceccarelli C, Taffurelli M, et al. Nuclear receptors agonists exert opposing effects on the inflammation dependent survival of breast cancer stem cells. Cell Death Differ 2012; 19:1208-19; PMID:22261616; http://dx.doi.org/10.1038/cdd.2011.207.
-
(2012)
Cell Death Differ
, vol.19
, pp. 1208-19
-
-
Papi, A.1
Guarnieri, T.2
Storci, G.3
Santini, D.4
Ceccarelli, C.5
Taffurelli, M.6
-
92
-
-
84868203536
-
All-transretinoic acid inhibits growth of head and neck cancer stem cells by suppression of Wnt/β-catenin pathway
-
PMID:22640830
-
Lim YC, Kang HJ, Kim YS, Choi EC. All-transretinoic acid inhibits growth of head and neck cancer stem cells by suppression of Wnt/β-catenin pathway. Eur J Cancer 2012; 48:3310-8; PMID:22640830; http://dx.doi.org/10.1016/j.ejca. 2012.04.013.
-
(2012)
Eur J Cancer
, vol.48
, pp. 3310-8
-
-
Lim, Y.C.1
Kang, H.J.2
Kim, Y.S.3
Choi, E.C.4
-
93
-
-
58049201990
-
The stem cellassociated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma
-
PMID:18802032
-
Rappa G, Fodstad O, Lorico A. The stem cellassociated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. Stem Cells 2008; 26:3008-17; PMID:18802032; http://dx.doi.org/10.1634/stemcells.2008- 0601.
-
(2008)
Stem Cells
, vol.26
, pp. 3008-17
-
-
Rappa, G.1
Fodstad, O.2
Lorico, A.3
-
94
-
-
78751702579
-
Photothermolysis of glioblastoma stemlike cells targeted by carbon nanotubes conjugated with CD133 monoclonal antibody
-
PMID:20620237
-
Wang CH, Chiou SH, Chou CP, Chen YC, Huang YJ, Peng CA. Photothermolysis of glioblastoma stemlike cells targeted by carbon nanotubes conjugated with CD133 monoclonal antibody. Nanomedicine 2011; 7:69-79; PMID:20620237; http://dx.doi.org/10.1016/j.nano.2010.06.010.
-
(2011)
Nanomedicine
, vol.7
, pp. 69-79
-
-
Wang, C.H.1
Chiou, S.H.2
Chou, C.P.3
Chen, Y.C.4
Huang, Y.J.5
Peng, C.A.6
-
95
-
-
77449145878
-
Targeting of cancer stem cell marker EpCAM by bispecific antibody EpCAMxCD3 inhibits pancreatic carcinoma
-
PMID:20196789
-
Salnikov AV, Groth A, Apel A, Kallifatidis G, Beckermann BM, Khamidjanov A, et al. Targeting of cancer stem cell marker EpCAM by bispecific antibody EpCAMxCD3 inhibits pancreatic carcinoma. J Cell Mol Med 2009; 13(9B):4023-33; PMID:20196789; http://dx.doi.org/10.1111/j.1582-4934.2009.00723.x.
-
(2009)
J Cell Mol Med
, vol.13
, Issue.9 B
, pp. 4023-33
-
-
Salnikov, A.V.1
Groth, A.2
Apel, A.3
Kallifatidis, G.4
Beckermann, B.M.5
Khamidjanov, A.6
-
96
-
-
84870372659
-
Specific inhibition of Notch1 signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cells
-
PMID:23041621
-
Qiu M, Peng Q, Jiang I, Carroll C, Han G, Rymer I, et al. Specific inhibition of Notch1 signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cells. Cancer Lett 2013; 328:261-70; PMID:23041621; http://dx.doi.org/10.1016/j.canlet.2012. 09.023.
-
(2013)
Cancer Lett
, vol.328
, pp. 261-70
-
-
Qiu, M.1
Peng, Q.2
Jiang, I.3
Carroll, C.4
Han, G.5
Rymer, I.6
-
97
-
-
62249169964
-
Differentiation therapy of acute myeloid leukemia: Past, present and future
-
PMID:19468269
-
Petrie K, Zelent A, Waxman S. Differentiation therapy of acute myeloid leukemia: Past, present and future. Curr Opin Hematol 2009; 16:84-91; PMID:19468269; http://dx.doi.org/10.1097/MOH.0b013e3283257aee.
-
(2009)
Curr Opin Hematol
, vol.16
, pp. 84-91
-
-
Petrie, K.1
Zelent, A.2
Waxman, S.3
|